Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Panbela Therapeutics, Inc. (SNBP)
|
Add to portfolio |
|
|
|
| Price: |
$1.88
| | Metrics |
| OS: |
2.96
|
M
| |
|
|
| Market cap: |
$5.56
|
M
| |
|
|
|
Net cash:
|
$2.01
|
M
| |
$0.68
|
per share
|
|
EV:
|
$3.55
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($34.1)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | | | | | | | | |
| Research and development | 28.0 | 5.4 | 2.5 | 2.3 | 1.8 | 2.6 | 2.5 | 2.9 |
| General and administrative | 6.0 | 4.6 | 3.2 | 2.0 | 2.1 | 3.4 | 2.7 | 2.6 |
| EBIT | -34.1 | -10.0 | -5.8 | -4.3 | -3.9 | -6.0 | -5.2 | -5.4 |
| EBIT margin | | | | | | | | |
| Pre-tax income | -35.0 | -10.6 | -5.1 | -6.6 | -6.2 | -10.9 | -5.5 | -5.7 |
| Income taxes | 0.1 | -0.5 | -0.3 | -0.4 | -0.3 | -0.5 | -0.3 | -0.8 |
| Tax rate | | 4.6% | 5.8% | 6.3% | 4.1% | 4.9% | 6.3% | 13.3% |
| Net income | -34.9 | -10.1 | -4.8 | -6.2 | -5.9 | -10.4 | -5.1 | -4.9 |
| Net margin | | | | | | | | |
| |
| Diluted EPS | ($67.85) | ($34.64) | ($0.62) | ($1.09) | ($1.27) | ($2.91) | ($1.65) | ($0.35) |
| Shares outstanding (diluted) | 0.5 | 0.3 | 7.7 | 5.7 | 4.7 | 3.6 | 3.1 | 14.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|